Latest filing published 27 Feb 2018 for Endo International plc, €721.
Daniel Rudio is a declared insider at 2 companies; the most frequent names are Endo International plc and Endo Pharmaceuticals Holdings Inc. The record holds 53 filings, for trades running from 21 February 2012 to 26 February 2018.
No open-market purchase appears, only 5 sales worth €91k. Outside the open market, there are 42 share grants.
The record was last updated on 27 February 2018 with a share grant (€435) in Endo International plc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 53 declarations